Objective: The aim of this study was to determine the pattern of hematological malignancies at Al-Gamhouria Teaching Hospital from 2008 to 2010.
Introduction
The pattern of hematological malignancies (HMs) in developing countries and developed countries differs. Among the different types of cancers, leukemia, lymphoma, and multiple myeloma appear to have greatly increased in frequency over the last 10 years. These malignancies are induced by genetic damage or mutation in somatic cells, which can result from environmental exposure to chemicals, ionizing radiation, and viral agents. Comparison of the incidence of HMs across geographic regions and time is complicated by the existence of different disease classification systems, and diagnostic criteria that vary by country, and even between hospitals and cancer registries (CRs) within a country [1] .
Leukemia is a malignant neoplasm of hematopoietic stem cells characterized by diffuse replacement of bone marrow or peripheral blood by neoplastic cells; its etiology is obscure [2] . Leukemia typing is based on how quickly the disease develops and progresses. Leukemia is either chronic or acute. Furthermore, leukemia typing is also based on the type of white blood cell that is affected. There are 4 common types of leukemia: acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL) [3, 4] . Most acute leukemias are classified as lymphoid or myeloid lineages via standard microscopic morphology, cytochemistry, and immunophenotyping [5] . Previous studies have shown that there are important differences in the incidence of the various leukemia subtypes according to geography, race/ethnicity, age, and trend pattern, indicating that the subtypes may have different etiological factors and that comprehensive global assessment of leukemia patterns is warranted [6, 7] .
Lymphomas are a heterogenous group of diseases with differences in epidemiology, histology, and prognosis. The incidence of Hodgkin's lymphoma (HL) and nonHodgkin's lymphoma (NHL) is higher among males than females. Malignant lymphoma is the most common malignant tumor in southeastern Yemen, has a high incidence (12.1%) in both genders, and is the most common type of cancer in males (M:F 1.6:1) [8] .
Multiple myeloma (MM) is included in the spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell leukemia. Plasma cell proliferation usually results in extensive skeletal destruction, with osteolytic lesions, hypercalcemia, anemia, and occasionally plasma cell infiltration in different organs. Excessive production of a monoclonal (M) protein can lead to renal failure, hyperviscosity syndrome, or recurrent bacterial infections [9] . The annual incidence of MM in the US is 3-4/100,000 and accounts for 1% of all cancers diagnosed in the US and MM accounts for approximately 10% of all hematological malignancies and 20% of all hematological malignancies in African Americans. Median age at onset of MM in US is 71 years [10] .
The aim of the present study was to determine the distribution and pattern of various HMs diagnosed at Al-Gamhouria Teaching Hospital, Aden, Yemen, and to compare them to those reported in other studies, so as to improve their diagnosis and treatment at our hospital.
Patients and Methods
All patients with HMs that were referred to, diagnosed, and managed at Al-Gamhouria Teaching Hospital (GTH), Department of Hematology-Oncology, Aden, Yemen, between 1 January 2008 and 30 December 2010 were included in the study. The Republic of Yemen has a population of approximately 22 million. GTH is one of the largest public hospitals in Yemen; it has 500 beds and pro- Anahtar Sözcükler: Malignansiler, Lenfoma, Lösemi, Multipl myelom, Aden Yemen rior iliac spine, as described by Dacie and Lewis [11] . The study protocol was approved by the Al-Gamhouria Teaching Hospital Ethics Committee.
Results
In total, 300 patients aged between18-80 years (mean age: 43.6 years) with a male:female ratio of 1.23:1 were diagnosed with malignant hematological disorders.
In table 1 NHL was the most common HM (37.66%), followed by HL (21.0%), AML (15.66 %), and ALL (7.66%). Among the chronic leukemia's, CML was more common than CLL (9.33% and 4.66%, respectively). In all, 12 patients had MM (4.0%). The 1-year relative survival rate was 87% in the HL patients, 75% in the CML patients, 72% in the CLL patients, 71% in the NHL patients, 35% in the ALL patients, and 18% in the AML patients. Table  2 shows that most of the patients with AML (29.7%) were vides services to more than 60,000 hospitalized patients and more than 600,000 outpatients annually.
Demographic data, including age and gender, and a detailed medical history were recorded for each patient. Each patient then underwent a detailed clinical examination, with particular emphasis on hematological parameters. Diagnoses were based on clinical features, blood counts, and peripheral blood films, and were confirmed via bone marrow cytology (Cytochemistry ;Myeloperoxidase and Periodic Acid Schiff) were used when indicated. Diagnosis of lymphoma was based primarily on documented histological reports. Other investigations performed for diagnosis or management included X-ray, creatinine, liver function, serum protein electrophoresis, serum total proteins, and albumin. Blood film examination for cell morphology was performed using Leishman's stain. Bone marrow was examined following aspiration of the poste- (Table 4) . Among the various histological subtypes, 47 (41.6%) patients had diffuse large cell lymphoma and 12 (10.6%) patients had lymphoblastic lymphoma.
Discussion
Lymphoma and leukemia are common in Yemen (24.8%) [8, 13, 14] . Malignant lymphoma constituted 58.7% of all diagnosed HMs in the present study; this high prevalence rate is in agreement with earlier reports from Yemen and the US [13, 15] . In the present study 23.3% of the patients had acute leukemias (AML and ALL), whereas CML was the fifth most common HM, accounted for 9.3% of patients and CLL accounted for 4.7%. In contrast, in Western countries CML accounts for 20% of leukemia subtypes and CLL accounts for 25% [16] .Similar results have been reported by Al-Ghazaly from Sana'a, Yemen [14] and by Noor et al. from Kenya, [17] whereas ALL was reported to be the most common HM in Karachi, [18] which indicates the geographic variability of the incidence of acute leukemia.
The incidence of lymphoma is increasing worldwide, largely due to NHL. [19] [20] [21] According to available data on cancer in southeastern Yemen (1983) (1984) (1985) (1986) (1987) (1988) (1989) , malignant lymphoma was the 2 nd most common malignancy; among males it ranked 2 nd and among females it ranked the 5 th . [13] Data from developed countries indicate a male:female ratio of 1.4:1, whereas in developing countries the ratio ranges from 4.5:1 to 3.1:1. In general, many more HMs have been reported to occur in males than in females; [22] However, in the present study the number of males and females with CML and CLL was equal, and a slightly higher number of females than males had AML. In the present study the male:female ratio for HL and ALL was aged 18-50 years and 73.9% of the ALL patients were aged 18-30 years. 21.4% of CML patients were aged 31-50 years and 57.1% of CLL patients were aged 51-60 years. NHL occurred in 24.8% patients aged 61-70 years, followed by 20.4% of those aged 51-60 years, whereas 58.7% of HL patients were aged 18-30 years. In general NHL with a follicular pattern of growth has a more favorable prognosis than NHL with a diffuse pattern-within the same cytological subtype. The growth pattern of NHL in the present study was diffuse in 59.3% of cases and follicular in only 14.2%, which is in sharp contrast to Western reports in which 30%-40% of all NHL cases are the follicular type [34] . In this study diffuse, mixed small and large cell lymphoma accounted for 9.7% of all the histological types, which is slightly higher than that reported from Western countries [33] . Moreover, 41.6% of NHL cases in the present study were diffuse large cell, without specification of the cell type. The frequency of Burkitt's lymphoma in the present study was with the lower than that reported in Ilorin, Nigeria but was similar study reported from Sudan [35] [36] .
113 (100) Total
The age-standardized incidence rate for leukemia (Table  5 ) is 8.8% in the US, 6.3% in Jordan, 5.4% in Egypt, 4.2% in Yemen, and 3.9% in Saudi Arabia. [25] [26] The agestandardized incidence rate for NHL in the US is among the highest in the world. Age-standardized incidence rate (ASR) in NHL have been reported to be low (6.5%) in East Asia, moderate (10.2%) in Africa and the Middle East, and high in Western Europe (17.9%), Australia( 25%) and Canada( 27.7%). International variation is due to differences in exposure to risk factors like the agricultural use of the pesticide 1,1,1-trichloro-2,2'bis (p-chlorophenyl)ethane (DDT) and increased risk of non-Hodgkin lymphoma.
[27] The incidence rate of NHL increased in in Western Europe and North America during the 1990s and has leveled off in recent years due in part to AIDS; however, NHL as a complication of AIDS does not occur in a sufficient proportion of AIDS cases to fully account for the extent of the increase. Other possible explanations for the high NHL incidence rate in Egypt may be the high prevalence of hepatitis C virus HCV infection. [28] Human papilloma Virus 8 HHV8 infection, adverse environmental exposure and pollution in those countries.
Mean survival in the present study was lower than that previously reported, [29, 30] and may have been due to several factors, including late presentation to hospital or a shortage of chemotherapeutic drugs. Improve outcome was reported for patients with early presentation and early stages of disease.
In the present study 45% of the patients with NHL and 53.7% of HL were aged 51-70 years and 18-30 years, respectively. In other studies the majority of NHL cases were aged 40-69 years-the peak age range being 50-59 years. In reports from Western countries HL was more prevalent among young adults (16 years) and the incidence of the disease makes pik late in the third decade of life (36 years), [31] which is similar to the present findings and indicates that there isn't a significant difference in incidence rate of HL based on age. The MM patients in the present study had a median age of 60 years, which is younger than previously reported [32] . The mean age reported by Inamullah et al. also matches with our study, while the mean age reported by Dispenzieri et al. in the US was 71 years, which was higher than our results [32] [33] . In our study the mean age in leukemia's agrees with previous studies in Africa [34] . The difference in the age incidence observed in this study when compared to the western countries may be due to the interplay of both environmental and racial factors. [34] 
